0000000001286415
AUTHOR
Akos F. Pap
showing 1 related works from this author
Rivaroxaban in Peripheral Artery Disease after Revascularization
2020
Abstract Background Patients with peripheral artery disease who have undergone lower-extremity revascularization are at high risk for major adverse limb and cardiovascular events. The efficacy and ...